Fundz

Terrain Biosciences

Cambridge, Massachusetts, United States · Biotechnology, Therapeutics · 11 employees

Terrain Biosciences is the world's first RNA design-build company, founded by Professors Omar Abudayyeh, Jonathan Gootenberg, and Patrick Hsu. The company leverages advanced AI models and proprietary technologies to accelerate the development of RNA-based therapeutics and vaccines. They aim to deliver RNA design and build services 3-6 times faster than industry standards for over a dozen therapeut

Funding history

  • Series seed — $9.0M — Feb 2025

Recent signals

  • Feb 14, 2025: Raised $9.0M in Series seed
  • Feb 12, 2025: Launched Terrain Biosciences launches as the first RNA design-build company, aiming to accelerate the development of programmable medicines using advanced AI.

See plans & pricing → Track Terrain Biosciences’s funding, hiring, and signals — with verified contacts — on Fundz.